Beta-adrenergic blocking therapy in thyrotoxicosis
Erikssen, J.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 90(11): 1206-1210
1970
ISSN/ISBN: 0029-2001 PMID: 4393742 Document Number: 27016
Document emailed within 1 workday
Related Documents
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Felt, V. 1970: Block of adrenergic beta-receptors by propranolol in the treatment of thyrotoxicosis Review of Czechoslovak Medicine 16(3): 140-144
Slawin, S. 1973: Beta adrenergic blocking drugs Harefuah 85(4): 178-183
Letts, L.G.; Easson, P.A.; Temple, D.M.; Williams, L.R.; Pasaribu, S.J.; Lap, B.V.; Lim, C.H. 1979: Beta-Adrenergic blocking action of halonitrophenethanolamines Archives Internationales de Pharmacodynamie et de Therapie 238(1): 105-113
Bruynzeel, P.L. 1984: Changes in the beta-adrenergic system due to beta-adrenergic therapy: clinical consequences European Journal of Respiratory Diseases. Supplement 135: 62-71
Colace, F. 1970: Pharmacology and clinical use of adrenergic beta-blocking agents Il Policlinico. Sezione Pratica 77(20): 645-656
Walters, L.; Dormehl, I.; Goosen, D.J.; Avenant, J.C.; Du Plessis, M.; Jacobs, N.; Schoeman, H.S. 1983: Beta-adrenergic blocking drugs and renal function South African Medical Journal 64(15): 572-573
Canale, J.M.; Horwitz, S. 1979: Therapeutic scope of beta-adrenergic blocking agents Archivos de Investigacion Medica 10(4): 261-277
Bauer, G.E.; Michell, G. 1970: Oxprenolol: clinical experiences with a new beta-adrenergic blocking drug Medical Journal of Australia 1(4): 170-173
Chan, P.S.; Ellenbogen, L. 1974: New evidence for the beta-adrenergic receptor blocking activity of dihydroergotamine Archives Internationales de Pharmacodynamie et de Therapie 209(2): 204-213
Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Gettes, L.S. 1970: Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias Cardiovascular Clinics 2(2): 211-237
Batlle, F.; Carreño, C.A.; Guetta, N.J.; Vassolo, E.; Bertolasi, C.A. 1970: Treatment of cardiac arrhythmias using a beta adrenergic receptor blocking drug Prensa Medica Argentina 57(38): 1801-1808
Rodrigues, R.; Kornfeld, J.; Pereira, E.M. 1972: Anti-arrhythmic effect of a new adrenergic beta receptor blocking substance Arquivos Brasileiros de Cardiologia 25(6): 471-475
Tafreshi, M.J.; Weinacker, A.B. 1999: Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma PharmacoTherapy 19(8): 974-978
Madan, B.R.; Gupta, R.S. 1970: Effect of adrenergic beta receptor blocking agents on cardiac output Indian Heart Journal 22(2): 70-72
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Apponi-Battini, G.; Barra, A.; De Simone, C.; Rossi, F.; Berrino, L.; Cazzola, M.; Marmo, E. 1984: Systemic and ocular effects of alpha 2-adrenergic stimulating and beta 2-blocking agents Journal of Medicine 15(2): 126-134
Nosál', R.; Drábiková, K.; Pecivová, J. 1988: Adverse effects of beta-adrenergic receptor blocking agents on the cellular level Casopis Lekaru Ceskych 127(5): 133-136